CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-267

Growth year on year was good, growth from previous quarter not so much, although still present, what the hit to the bottom line is from the investing for growth will need to wait for annual report and how much the investment in growth helps the top line probably waiting for an update at the AGM, unless they are bullish with release of annual report.

otherwise, there seems to be a lot of supply available ever since the first capital raise post the capital return capping upside.

seems like it will take maybe cashflow positivity, as no insto seems to be willing to bid up the price currently to obtain supply.

it should get there but it's not guaranteed, it also hasn't been a strong market for microcaps and return from fixed interest has increased